Correlation Between Werewolf Therapeutics and MiMedx
Can any of the company-specific risk be diversified away by investing in both Werewolf Therapeutics and MiMedx at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Werewolf Therapeutics and MiMedx into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Werewolf Therapeutics and MiMedx Group, you can compare the effects of market volatilities on Werewolf Therapeutics and MiMedx and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Werewolf Therapeutics with a short position of MiMedx. Check out your portfolio center. Please also check ongoing floating volatility patterns of Werewolf Therapeutics and MiMedx.
Diversification Opportunities for Werewolf Therapeutics and MiMedx
0.7 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Werewolf and MiMedx is 0.7. Overlapping area represents the amount of risk that can be diversified away by holding Werewolf Therapeutics and MiMedx Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on MiMedx Group and Werewolf Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Werewolf Therapeutics are associated (or correlated) with MiMedx. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of MiMedx Group has no effect on the direction of Werewolf Therapeutics i.e., Werewolf Therapeutics and MiMedx go up and down completely randomly.
Pair Corralation between Werewolf Therapeutics and MiMedx
Given the investment horizon of 90 days Werewolf Therapeutics is expected to under-perform the MiMedx. In addition to that, Werewolf Therapeutics is 2.11 times more volatile than MiMedx Group. It trades about -0.12 of its total potential returns per unit of risk. MiMedx Group is currently generating about -0.2 per unit of volatility. If you would invest 948.00 in MiMedx Group on December 29, 2024 and sell it today you would lose (194.00) from holding MiMedx Group or give up 20.46% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 100.0% |
Values | Daily Returns |
Werewolf Therapeutics vs. MiMedx Group
Performance |
Timeline |
Werewolf Therapeutics |
MiMedx Group |
Werewolf Therapeutics and MiMedx Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Werewolf Therapeutics and MiMedx
The main advantage of trading using opposite Werewolf Therapeutics and MiMedx positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Werewolf Therapeutics position performs unexpectedly, MiMedx can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in MiMedx will offset losses from the drop in MiMedx's long position.Werewolf Therapeutics vs. Monte Rosa Therapeutics | Werewolf Therapeutics vs. Design Therapeutics | Werewolf Therapeutics vs. Ikena Oncology | Werewolf Therapeutics vs. Stoke Therapeutics |
MiMedx vs. Monte Rosa Therapeutics | MiMedx vs. Design Therapeutics | MiMedx vs. Werewolf Therapeutics | MiMedx vs. Ikena Oncology |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.
Other Complementary Tools
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |